Review: Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease

Review: Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease

Cannabis and its derivatives can have beneficial but also detrimental effects on gastrointestinal and hepatic function, via the endocannabinoid system (ECS). These are discussed in a review article in the July issue of Gastroenterology. Cannabis and its derivatives affect many gastrointestinal processes via the ECS and has reported anti-inflammatory, anti-nociceptive,

Read more
  • Real-Time Views of Gastrointestinal Motility

Real-Time Views of Gastrointestinal Motility

Bioengineers have found a way to visualize the action of the gastrointestinal tract in real-time, developing a non-invasive means to observe the wave-like muscle contractions that occur during peristalsis. According to the NIH Director’s blog, new technologies are needed to aid in diagnosis and treatment of the wide range of

Read more

How Does an Antibiotic Reduce Symptoms of IBS?

Rifaximin alters the intestinal microbiota to prevent inflammation and visceral hyperalgesia in stressed rats, according to the February issue of Gastroenterology. These findings could explain the ability of this antibiotic to relieve symptoms of irritable bowel syndrome (IBS) in patients. Rifaximin is a broad-spectrum antibiotic that has been approved by

Read more